K020828Substantially Equivalent
Ca 125 Assay for the Advia Centaur System
Bayer Corp., Tarrytown NY / Traditional, Substantially Equivalent
K020828 is the FDA 510(k) clearance record for CA 125 ASSAY FOR THE ADVIA CENTAUR SYSTEM, a class II device, cleared for Bayer Corp. on under FDA product code LTK (Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125)). FDA records list 63 510(k) clearances for Bayer Corp., from to . As of , FDA records show 2 recalls naming K020828.
Clearance record
- Decision date
- Received
- (132 days to decision)
- Product code
- LTK Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125)
- Regulation
- 21 CFR 866.6010
- Device class
- Class II
- Review panel
- Immunology
- Applicant
- Bayer Corp. 511 Benedict Ave., Tarrytown NY
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code LTK
Trailing 12 monthsFDA records hold no clearances under product code LTK in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
